A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis

Journal of Experimental Medicine

Volumn 210, Issue 12, 2013, Pages 2569-2582

  Scally, Stephen W ^a   Petersen, Jan ^a   Law, Soi Cheng ^b   Dudek, Nadine L ^a   Nel, Hendrik J ^b   Loh, Khai Lee ^a   Wijeyewickrema, Lakshmi C ^a   Eckle, Sidonia B G ^c   Heemst, Jurgen Van ^d   Pike, Robert N ^a   McCluskey, James ^c   Toes, Rene E ^d   La Gruta, Nicole L ^c   Purcell, Anthony W ^a   Reid, Hugh H ^a   Thomas, Ranjeny ^b   Rossjohn, Jamie ^a,e  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ARGININE; CITRULLINE; HLA DRB1 ANTIGEN; PROTEINASE; TETRAMER; VIMENTIN;

ADULT; ARTICLE; BLOOD; CITRULLINATION; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; GENETIC ASSOCIATION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN PROCESSING; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

AGGRECANS; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CITRULLINE; EPITOPES; GENETIC ASSOCIATION STUDIES; HLA-DR BETA-CHAINS; HLA-DR4 ANTIGEN; HLA-DRB1 CHAINS; HUMANS; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; VIMENTIN;

EID: 84888116736     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131241     Document Type: Article

References (55)

1. Abadie, V., L.M. Sollid, L.B. Barreiro, and B. Jabri. 2011. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu. Rev. Immunol. 29:493-525. http://dx.doi.org/10.1146/annurev-immunol-040210-092915
2. Aletaha, D., T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham III, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, M.D. Cohen, et al. 2010. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62:2569-2581. http://dx.doi.org/10.1002/art .27584
3. Aricescu, A.R., W. Lu, and E.Y. Jones. 2006. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D Biol. Crystallogr. 62:1243-1250. http://dx.doi.org/10.1107/S0907444906029799
4. Bailey, T.L., M. Boden, F.A. Buske, M. Frith, C.E. Grant, L. Clementi, J. Ren, W.W. Li, and W.S. Noble. 2009. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37:W202-8. http://dx.doi .org/10.1093/nar/gkp091
5. Bharadwaj, M., P. Illing, A. Theodossis, A.W. Purcell, J. Rossjohn, and J. McCluskey. 2012. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu. Rev. Pharmacol. Toxicol. 52:401-431. http://dx.doi.org/10.1146/annurev-pharmtox-010611-134701
6. Bongartz, T., T. Cantaert, S.R. Atkins, P. Harle, J.L. Myers, C. Turesson, J.H. Ryu, D. Baeten, and E.L. Matteson. 2007. Citrullination in extraarticular manifestations of rheumatoid arthritis. Rheumatology. 46:70-75. http://dx.doi.org/10.1093/rheumatology/kel202
7. Brömme, D., Z. Li, M. Barnes, and E. Mehler. 1999. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry. 38:2377-2385. http://dx.doi.org/10.1021/bi982175f
8. Broughton, S.E., J. Petersen, A. Theodossis, S.W. Scally, K.L. Loh, A. Thompson, J. van Bergen, Y. Kooy-Winkelaar, K.N. Henderson, T. Beddoe, et al. 2012. Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity. 37:611-621. http://dx.doi.org/10.1016/j.immuni.2012.07.013
9. Colaert, N., K. Helsens, L. Martens, J. Vandekerckhove, and K. Gevaert. 2009. Improved visualization of protein consensus sequences by iceLogo. Nat. Methods. 6:786-787. http://dx.doi.org/10.1038/nmeth1109-786
10. Dessen, A., C.M. Lawrence, S. Cupo, D.M. Zaller, and D.C. Wiley. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity. 7:473-481. http://dx.doi.org/10.1016/S1074-7613(00)80369-6
11. Dudek, N.L., C.T. Tan, D.G. Gorasia, N.P. Croft, P.T. Illing, and A.W. Purcell. 2012. Constitutive and inflammatory immunopeptidome of pancreatic β-cells. Diabetes. 61:3018-3025. http://dx.doi.org/10.2337/db11-1333
12. Foulquier, C., M. Sebbag, C. Clavel, S. Chapuy-Regaud, R. Al Badine, M.C. Méchin, C. Vincent, R. Nachat, M. Yamada, H. Takahara, et al. 2007. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56:3541-3553. http://dx.doi.org/10.1002/art.22983
13. Gregersen, P.K., J. Silver, and R.J. Winchester. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205-1213. http://dx.doi.org/10.1002/art.1780301102
14. Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLADR-binding peptides. Cell. 74:197-203. http://dx.doi.org/10.1016/0092-8674(93)90306-B
15. Hammer, J., F. Gallazzi, E. Bono, R.W. Karr, J. Guenot, P. Valsasnini, Z.A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847-1855. http://dx.doi.org/10.1084/jem.181.5.1847
16. Harre, U., D. Georgess, H. Bang, A. Bozec, R. Axmann, E. Ossipova, P.J. Jakobsson, W. Baum, F. Nimmerjahn, E. Szarka, et al. 2012. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122:1791-1802. http://dx.doi.org/10.1172/JCI60975
17. Helmick, C.G., D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, et al; National Arthritis Data Workgroup. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58:15-25. http://dx.doi.org/10.1002/art.23177
18. Henderson, K.N., J.A. Tye-Din, H.H. Reid, Z. Chen, N.A. Borg, T. Beissbarth, A. Tatham, S.I. Mannering, A.W. Purcell, N.L. Dudek, et al. 2007. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity. 27:23-34. http://dx.doi.org/10.1016/j.immuni.2007.05.015
19. Hill, J.A., S. Southwood, A. Sette, A.M. Jevnikar, D.A. Bell, and E. Cairns. 2003. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 171:538-541.
20. Hill, J.A., D.A. Bell, W. Brintnell, D. Yue, B. Wehrli, A.M. Jevnikar, D.M. Lee, W. Hueber, W.H. Robinson, and E. Cairns. 2008. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J. Exp. Med. 205:967-979. http://dx.doi.org/10.1084/jem.20072051
21. Hsieh, C.S., Y. Liang, A.J. Tyznik, S.G. Self, D. Liggitt, and A.Y. Rudensky. 2004. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity. 21:267-277. http://dx.doi .org/10.1016/j.immuni.2004.07.009
22. Huizinga, T.W., C.I. Amos, A.H. van der Helm-van Mil, W. Chen, F.A. van Gaalen, D. Jawaheer, G.M. Schreuder, M. Wener, F.C. Breedveld, N. Ahmad, et al. 2005. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 52:3433-3438. http://dx.doi.org/10.1002/art.21385
23. Illing, P.T., J.P. Vivian, N.L. Dudek, L. Kostenko, Z. Chen, M. Bharadwaj, J.J. Miles, L. Kjer-Nielsen, S. Gras, N.A. Williamson, et al. 2012. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature. 486:554-558.
24. Jones, E.Y., L. Fugger, J.L. Strominger, and C. Siebold. 2006. MHC class II proteins and disease: a structural perspective. Nat. Rev. Immunol. 6:271-282. http://dx.doi.org/10.1038/nri1805
25. Klareskog, L., J. Rönnelid, K. Lundberg, L. Padyukov, and L. Alfredsson. 2008. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26:651-675. http://dx.doi.org/10.1146/annurev.immunol.26 .021607.090244
26. Klareskog, L., A.I. Catrina, and S. Paget. 2009. Rheumatoid arthritis. Lancet. 373:659-672. http://dx.doi.org/10.1016/S0140-6736(09)60008-8
27. Kuhn, K.A., L. Kulik, B. Tomooka, K.J. Braschler, W.P. Arend, W.H. Robinson, and V.M. Holers. 2006. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116:961-973. http://dx.doi.org/10.1172/JCI25422
28. Law, S.C., S. Street, C.H. Yu, C. Capini, S. Ramnoruth, H.J. Nel, E. van Gorp, C. Hyde, K. Lau, H. Pahau, et al. 2012. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res. Ther. 14:R118. http://dx.doi.org/10.1186/ar3848
29. Li, G., D. Diogo, D. Wu, J. Spoonamore, V. Dancik, L. Franke, F. Kurreeman, E.J. Rossin, G. Duclos, C. Hartland, et al; Rheumatoid Arthritis Consortium International (RACI). 2013. Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway. PLoS Genet. 9:e1003487. http://dx.doi.org/10.1371/journal.pgen.1003487
30. Lundberg, K., A. Kinloch, B.A. Fisher, N. Wegner, R. Wait, P. Charles, T.R. Mikuls, and P.J. Venables. 2008. Antibodies to citrullinated alphaenolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58:3009-3019. http://dx.doi.org/10.1002/art.23936
31. Makrygiannakis, D., M. Hermansson, A.K. Ulfgren, A.P. Nicholas, A.J. Zendman, A. Eklund, J. Grunewald, C.M. Skold, L. Klareskog, and A.I. Catrina. 2008. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum. Dis. 67:1488-1492. http://dx.doi.org/10.1136/ard .2007.075192
32. Mallone, R., S.A. Kochik, H. Reijonen, B. Carson, S.F. Ziegler, W.W. Kwok, and G.T. Nepom. 2005. Functional avidity directs T-cell fate in autoreactive CD4+ T cells. Blood. 106:2798-2805. http://dx.doi.org/10.1182/blood-2004-12-4848
33. Mannering, S.I., L.C. Harrison, N.A. Williamson, J.S. Morris, D.J. Thearle, K.P. Jensen, T.W. Kay, J. Rossjohn, B.A. Falk, G.T. Nepom, and A.W. Purcell. 2005. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J. Exp. Med. 202:1191-1197. http://dx.doi.org/10.1084/jem.20051251
34. Miyara, M., Y. Yoshioka, A. Kitoh, T. Shima, K. Wing, A. Niwa, C. Parizot, C. Taflin, T. Heike, D. Valeyre, et al. 2009. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 30:899-911. http://dx.doi.org/10.1016/j.immuni.2009.03.019
35. Miyara, M., G. Gorochov, M. Ehrenstein, L. Musset, S. Sakaguchi, and Z. Amoura. 2011. Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun. Rev. 10:744-755. http://dx.doi.org/10.1016/j.autrev.2011.05.004
36. Padyukov, L., C. Silva, P. Stolt, L. Alfredsson, and L. Klareskog. 2004. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 50:3085-3092. http://dx.doi.org/10.1002/art.20553
37. Pang, S.S., R. Berry, Z. Chen, L. Kjer-Nielsen, M.A. Perugini, G.F. King, C. Wang, S.H. Chew, N.L. La Gruta, N.K. Williams, et al. 2010. The structural basis for autonomous dimerization of the pre-T-cell antigen receptor. Nature. 467:844-848. http://dx.doi.org/10.1038/nature09448
38. Petersen, J., A.W. Purcell, and J. Rossjohn. 2009. Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J. Mol. Med. 87:1045-1051. http://dx.doi.org/10.1007/s00109-009-0526-4
39. Pettit, A.R., K.P. MacDonald, B. O'Sullivan, and R. Thomas. 2000. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum. 43:791-800. http://dx.doi.org/10.1002/1529-0131(200004)43:4<791::AID-ANR9>3.0.CO;2-E
40. Raychaudhuri, S., C. Sandor, E.A. Stahl, J. Freudenberg, H.S. Lee, X. Jia, L. Alfredsson, L. Padyukov, L. Klareskog, J. Worthington, et al. 2012. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44:291-296. http://dx.doi.org/10.1038/ng.1076
41. Reeves, P.J., N. Callewaert, R. Contreras, and H.G. Khorana. 2002. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc. Natl. Acad. Sci. USA. 99:13419-13424. http://dx.doi .org/10.1073/pnas.212519299
42. Scarsi, M., T. Ziglioli, and P. Airò. 2010. Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response. J. Rheumatol. 37:911-916. http://dx.doi.org/10.3899/jrheum.091176
43. Schönland, S.O., C. Lopez, T. Widmann, J. Zimmer, E. Bryl, J.J. Goronzy, and C.M. Weyand. 2003. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc. Natl. Acad. Sci. USA. 100:13471-13476. http://dx.doi .org/10.1073/pnas.2233561100
44. Sempere-Ortells, J.M., V. Pérez-García, G. Marín-Alberca, A. Peris-Pertusa, J.M. Benito, F.M. Marco, J.J. Zubcoff, and F.J. Navarro-Blasco. 2009. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28. Autoimmunity. 42:636-645. http://dx.doi.org/10.3109/08916930903061491
45. Sette, A., J. Sidney, C. Oseroff, M.F. del Guercio, S. Southwood, T. Arrhenius, M.F. Powell, S.M. Colón, F.C. Gaeta, and H.M. Grey. 1993. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163-3170.
46. Snir, O., M. Rieck, J.A. Gebe, B.B. Yue, C.A. Rawlings, G. Nepom, V. Malmström, and J.H. Buckner. 2011. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLADRB1* 0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 63:2873-2883. http://dx.doi.org/10.1002/art.30445
47. Su, L.F., B.A. Kidd, A. Han, J.J. Kotzin, and M.M. Davis. 2013. Virusspecific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity. 38:373-383. http://dx.doi.org/10.1016/j.immuni.2012.10.021
48. Tung, J.W., K. Heydari, R. Tirouvanziam, B. Sahaf, D.R. Parks, L.A. Herzenberg, and L.A. Herzenberg. 2007. Modern flow cytometry: a practical approach. Clin. Lab. Med. 27:453-468: v (v.). http://dx.doi .org/10.1016/j.cll.2007.05.001
49. van der Woude, D., B.A. Lie, E. Lundström, A. Balsa, A.L. Feitsma, J.J. Houwing-Duistermaat, W. Verduijn, G.B. Nordang, L. Alfredsson, L. Klareskog, et al. 2010. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum. 62:1236-1245. http://dx.doi.org/10.1002/art.27366
50. van Gaalen, F.A., J. van Aken, T.W. Huizinga, G.M. Schreuder, F.C. Breedveld, E. Zanelli, W.J. van Venrooij, C.L. Verweij, R.E. Toes, and R.R. de Vries. 2004. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50:2113-2121. http://dx.doi .org/10.1002/art.20316
51. Viatte, S., D. Plant, and S. Raychaudhuri. 2013. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol. 9:141-153. http://dx.doi .org/10.1038/nrrheum.2012.237
52. von Delwig, A., J. Locke, J.H. Robinson, and W.F. Ng. 2010. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum. 62:143-149. http://dx.doi .org/10.1002/art.25064
53. Vossenaar, E.R., and W.J. van Venrooij. 2004. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res. Ther. 6:107-111. http://dx.doi.org/10.1186/ar1184
54. Vossenaar, E.R., T.R. Radstake, A. van der Heijden, M.A. van Mansum, C. Dieteren, D.J. de Rooij, P. Barrera, A.J. Zendman, and W.J. van Venrooij. 2004. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 63:373-381. http://dx.doi.org/10.1136/ard.2003.012211
55. Wegner, N., K. Lundberg, A. Kinloch, B. Fisher, V. Malmström, M. Feldmann, and P.J. Venables. 2010. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233:34-54. http://dx.doi.org/10.1111/j.0105-2896.2009.00850.x